Ro Partners With Eli Lilly To Streamline Zepbound Access Through Seamless Platform

Benzinga

Direct-to-consumer health startup Ro has partnered with Eli Lilly to provide more affordable single-dose vials of the weight-loss drug Zepbound, streamlining access through a seamless platform. The initiative integrates Ro’s services with LillyDirect, enabling eligible patients to receive diagnoses, prescriptions, and home delivery of Zepbound via Gifthealth. Ro states that Zepbound vials offer the lowest price for a branded GLP-1 drug before insurance. Demand for GLP-1 medications, which help control appetite and blood sugar, has surged over the past two years.

Transcript

00:00It's Benzinga, bringing Wall Street to Main Street.

00:02Direct-to-consumer health startup Rowe has partnered with Eli Lilly to provide more affordable

00:06single-dose vials of the affordable weight loss drug, ZepBound, streamlining access through

00:11a seamless platform.

00:13The initiative integrates Rowe Services with Lilly Direct, enabling eligible patients to

00:17receive diagnosis, prescriptions, and home delivery of ZepBound via GiftHealth.

00:23Rowe states that ZepBound vials offer the lowest price for a branded GLP-1 drug before

00:28insurance.

00:29Demand for GLP-1 medications, which help control appetite and blood sugar, has surged over

00:34the past two years.

00:35For all things money, visit Benzinga.com slash GSTV.

Category

Transcript

Comments

Recommended